Company intelligence / Profile preview

BHealthCare

Ownership: Private
Employees: ~35
Development stage: Commercial

Overview

BHealthCare has developed HEIVA, an autonomous medical robot designed to improve the accuracy and patient experience of blood draws. The device aims to provide a high first-stick success rate, reduce pain/stress associated with venipuncture, standardize preanalytical processes, and enhance sample quality. As of 2024, agreements have been signed with three European labs for over 30 pre-orders. The product is advancing toward regulatory approvals in Europe and the Gulf Cooperation Council region. No clinical trial results are published yet.

Therapeutic areas: Hematology
Modalities: DeviceNon-pharmacological therapy
Industry: Surgical Medical Devices

Partnerships

Agreements signed with three European medical laboratories for pilot/pre-order deployments

Beyond the preview

Go deeper on BHealthCare.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BHealthCare.

Explore the full profile